Trial intelligence / Profile preview

Topical urethral anesthetic gels for catheter-related bladder discomfort after ureteroscopic lithotripsy

ChiCTR2500105477Phase 4Recruiting

Sponsor
International Zhuang Medical Hospital of Guangxi University of Traditional Chinese Medicine
Start
Jul 2025
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of tetracaine, oxybuprocaine and dyclonine in Lithiasis, ureterolithiasis, nephrolithiasis and 2 more (3 arms), sponsored by International Zhuang Medical Hospital of Guangxi University of Traditional Chinese Medicine. Primary endpoint: Catheter-related bladder discomfort (CRBD). Started Jul 2025; status: recruiting.

02

Drugs

tetracaineoxybuprocainedyclonine
03

Conditions

Lithiasisureterolithiasisnephrolithiasiscystitisurethral syndrome

Beyond the preview

Go deeper on ChiCTR2500105477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500105477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call